DarioHealth Corp. filed an 8-K on November 2, 2026, announcing it will release third-quarter financial results for the period ended September 30, 2026, and host a conference call and webcast at 8:30 a.m. Eastern Time on Thursday, November 12, 2026.

Key Highlights

  • Earnings release date: Financial results for Q3 2026 (quarter ended September 30, 2026) will be released before the market opens on November 12, 2026.
  • Call hosts: CEO Erez Raphael, COO Lara Dodo, and CFO Chen Franco-Yehuda will lead the conference call.
  • Replay availability: A replay of the call will be accessible approximately three hours after completion and will remain available through Thursday, November 26, 2026.
  • Platform scale: According to the filing, DarioHealth's AI platform is powered by more than 13 billion proprietary longitudinal healthcare data points collected over more than a decade.
  • Conditions addressed: The company's integrated platform supports individuals living with diabetes, hypertension, weight management, musculoskeletal, and behavioral health conditions, per the filing.

DarioHealth Schedules Q3 2026 Results Event Before Market Open

DarioHealth Corp. (NASDAQ:DRIO) disclosed via press release that its third-quarter 2026 earnings call is set for November 12, 2026, at 8:30 a.m. Eastern Time, before the market opens. Three members of the company's senior leadership team are named as hosts: Erez Raphael, Chief Executive Officer; Lara Dodo, Chief Operations Officer; and Chen Franco-Yehuda, Chief Financial Officer. The filing noted that participants are asked to dial in approximately 10 minutes prior to the scheduled start time.

According to the filing, a webcast link is being provided in addition to dial-in access, and a replay will become available roughly three hours after the call concludes, remaining accessible through November 26, 2026, using replay passcode 1139413. The filing also described DarioHealth as "an AI-powered healthcare technology company helping health plans, health systems and employers improve health outcomes while lowering the cost of care." The company's platform, as characterized in the filing, combines connected devices, personalized member engagement, AI-driven insights, and provider-backed clinical care within a single integrated solution.

The filing states that DarioHealth's AI platform personalizes care at the individual member level by analyzing biometric, clinical, and behavioral data drawn from more than 13 billion proprietary longitudinal healthcare data points accumulated over more than a decade. The filing includes cautionary language noting that forward-looking statements, including the expected date of the earnings release, are subject to factors that could cause actual results to differ materially, and that the company undertakes no obligation to update such statements except as required by applicable law.

What Was Disclosed

DarioHealth Corp. announced the date, time, and access details for its Q3 2026 earnings conference call and webcast, scheduled for November 12, 2026. The filing named three company executives as hosts and provided replay access information through November 26, 2026.